Correlation Between Seres Therapeutics and Syros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Syros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Syros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Syros Pharmaceuticals, you can compare the effects of market volatilities on Seres Therapeutics and Syros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Syros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Syros Pharmaceuticals.
Diversification Opportunities for Seres Therapeutics and Syros Pharmaceuticals
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Seres and Syros is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Syros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syros Pharmaceuticals and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Syros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syros Pharmaceuticals has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Syros Pharmaceuticals go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Syros Pharmaceuticals
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 0.35 times more return on investment than Syros Pharmaceuticals. However, Seres Therapeutics is 2.89 times less risky than Syros Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Syros Pharmaceuticals is currently generating about -0.14 per unit of risk. If you would invest 70.00 in Seres Therapeutics on August 28, 2024 and sell it today you would earn a total of 19.00 from holding Seres Therapeutics or generate 27.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Syros Pharmaceuticals
Performance |
| Timeline |
| Seres Therapeutics |
| Syros Pharmaceuticals |
Seres Therapeutics and Syros Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Syros Pharmaceuticals
The main advantage of trading using opposite Seres Therapeutics and Syros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Syros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will offset losses from the drop in Syros Pharmaceuticals' long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Syros Pharmaceuticals vs. Surrozen | Syros Pharmaceuticals vs. Bolt Biotherapeutics | Syros Pharmaceuticals vs. Larimar Therapeutics | Syros Pharmaceuticals vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |